We are live on ! Find out more
CRMD icon

CorMedix
CRMD

41 hedge funds and large institutions have $20.7M invested in CorMedix in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 2

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

103% more call options, than puts

Call options by funds: $318K | Put options by funds: $157K

101% more capital invested

Capital invested by funds: $10.3M → $20.7M (+$10.4M)

24% more funds holding

Funds holding: 33 → 41 (+8)

0.87% more ownership

Funds ownership: 2.17% → 3.04% (+0.87%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
41
Holders Change
+8
Holders Change %
+24.24%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
16
Reduced
2
Closed
4
Calls
$318K
Puts
$157K
Net Calls
+$161K
Net Calls Change
+$254K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.96M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$151K
4
Wells Fargo
Wells Fargo
California
+$141K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$109K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$382K
2
EI
EAM Investors
California
-$173K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$98.4K
4
Citadel Advisors
Citadel Advisors
Florida
-$32.9K
5
AWA
Arete Wealth Advisors
Illinois
-$24K

CRMD Hedge Fund Activity: Q4 2018 in Review

41 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q4 2018, worth a combined $20.7M — up 101% from $10.3M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CRMD positions and 4 closed out — a net gain of 8 holders — while 16 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, adding an estimated $2.8M. The largest seller was Virtu Financial, exiting entirely with an estimated $382K sold.

  • 41 institutional investors held CorMedix (CRMD) as of Q4 2018, up from 33 in Q3 2018.
  • Funds reported $20.7M of CorMedix stock for Q4 2018, up 101% quarter-over-quarter.
  • 12 funds opened new CorMedix positions in Q4 2018 and 4 closed out, a net change of +8 holders.
  • The largest CorMedix buyer in Q4 2018 was BlackRock, an estimated $2.8M added.
  • The largest CorMedix seller in Q4 2018 was Virtu Financial, an estimated $382K sold.

Based on aggregated 13F filings for Q4 2018.